Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | APP | P05067 | 1/20 | 0.63 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.63 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.63 |
| ▸ | F7 | P08709 | 1/20 | 0.61 |
| ▸ | F3 | P13726 | 1/20 | 0.61 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.61 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.61 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.61 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.61 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.61 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.61 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacin SCHEMBL679551 | 0.98 | ALDH1A1 (0.61) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL3498987 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL587526 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL6012008 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL25269786 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL23780930 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL308681 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL1943861 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL10357700 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Niacin SCHEMBL987479 | 0.96 | ALDH1A1 (0.63) | ALDH1A1GAAAPPHCAR3HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034137-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2026-02-05 | — | — | US | claimed |
| US-20230149412-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2023-05-18 | — | — | US | claimed |
| US-20230149488-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2023-05-18 | — | — | US | claimed |
| US-20230025435-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELLULAR VITALITY AND LONGEVITY AND DECREASING MOLECULAR AGEING | JUVN3 HOLDINGS, LLC (US) | 2023-01-26 | — | — | US | claimed |
| US-20260034137-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20230149412-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230149488-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | JUVN3 HOLDINGS, LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230025435-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELLULAR VITALITY AND LONGEVITY AND DECREASING MOLECULAR AGEING | JUVN3 HOLDINGS, LLC (US) | 2023-01-26 | — | — | US | disclosed |
| US-20220288211-A1 | DOSAGE-INDICATING TOPICAL FORMULATION AND METHOD OF USING A DOSAGE-INDICATING TOPICAL FORMULATION | Younger Phenotype Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| CN-114980906-A | Compositions and methods for increasing cell viability and longevity and reducing molecular aging | JUVN3控股有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-109123101-B | Preparation method of manganese nicotinate | 长沙兴嘉生物工程股份有限公司 | 2022-02-11 | — | — | CN | disclosed |
| WO-2021141955-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELLULAR VITALITY AND LONGEVITY AND DECREASING MOLECULAR AGEING | JUVN3 HOLDINGS, LLC (US) | 2021-07-15 | — | — | WO | disclosed |
| US-10258980-B2 | Pure chelation process | C LAB PHARMA INTERNATIONAL, S.A. (VG) | 2019-04-16 | — | — | US | disclosed |
| US-20170274370-A1 | PURE CHELATION PROCESS | C LAB PHARMA INTERNATIONAL, S.A. (VG) | 2017-09-28 | — | — | US | disclosed |
| EP-3188835-A1 | PURE CHELATION PROCESS | C Lab Pharma International, S.A. (VG) | 2017-07-12 | — | — | EP | disclosed |
| CN-105754331-A | Polyamide Resin Composition And Molded Article | 旭化成株式会社 | 2016-07-13 | — | — | CN | disclosed |
| WO-2016037181-A1 | PURE CHELATION PROCESS | C LAB PHARMA INTERNATIONAL, S.A. (VG) | 2016-03-10 | — | — | WO | disclosed |
| US-20130184247-A1 | METHOD FOR PREPARATION OF NICOTINIC ACID COPPER CHLORIDE COMPLEX, AND ITS PHARMACEUTICAL USES | HUSSEIN ALY IBRAHEIM SALAH FATHIY (EG) | 2013-07-18 | — | — | US | disclosed |
| US-20110274773-A1 | Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same | HUSSEIN ALY IBRAHEIM SALAH FATHIY | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034137-A1 | Compositions and Methods for Cellular Ageing, Stress Resilience, Autophagy, Inflammation and Longevity | TFAM, POT1, CLPX | ALDH1A1 2977/4885GAA 463/4885APP 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.